Literature DB >> 8840060

Determination of end-tidal sevoflurane concentration for tracheal intubation in children with the rapid method.

S Inomata1, T Nishikawa.   

Abstract

PURPOSE: Using the conventional method of determining the end-tidal concentration of inhalational anaesthetic for tracheal intubation, a constant end-tidal anaesthetic concentration is maintained for at least 15 min. As sevoflurane has a low tissue/gas partition coefficient, it seems possible in paediatric patients to determine end-tidal concentrations for tracheal intubation more rapidly by using a high inspired concentration. We determined ED50 and ED95 of sevoflurane for tracheal intubation, the end-tidal concentrations that prevented 50% and 95% of patients from coughing and gross purposeful muscular movements after intubation.
METHODS: Twenty-nine, ASA 1, unpremedicated patients, aged two to eight years, were enrolled. Anaesthesia was induced using a mask and 5% sevoflurane, inspired, in oxygen. When end-tidal sevoflurane concentration attained a predetermined value, laryngoscopy and tracheal intubation were performed using an uncuffed tracheal tube without neuromuscular relaxants or adjuvants. Each concentration at which laryngoscopy and tracheal intubation were attempted was randomly predetermined (with 0.5% as a step size). When tracheal intubation was accomplished without gross purposeful muscular movements, it was considered a smooth tracheal intubation.
RESULTS: The ED50 end-tidal sevoflurane concentration for tracheal intubation was 3.10% (95% confidence limits: 2.43% and 3.78%), and the ED95 was 4.68% (95% confidence limits: 3.91% and 12.74%). The times to end-tidal sevoflurane concentrations of 3.0% and 4.5% were 149 +/- 15 sec (mean +/- SD) and 213 +/- 23 sec.
CONCLUSION: In paediatric patients, this method enabled determination of ED50 and ED95 end-tidal sevoflurane concentrations for tracheal intubation without obtaining a long stabilization period.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8840060     DOI: 10.1007/BF03013033

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  14 in total

1.  The minimum alveolar concentration (MAC) and hemodynamic effects of halothane, isoflurane, and sevoflurane in newborn swine.

Authors:  J Lerman; J P Oyston; T M Gallagher; K Miyasaka; G A Volgyesi; F A Burrows
Journal:  Anesthesiology       Date:  1990-10       Impact factor: 7.892

2.  End-tidal halothane concentration for endotracheal intubation.

Authors:  R W Yakaitis; C D Blitt; J P Angiulo
Journal:  Anesthesiology       Date:  1977-10       Impact factor: 7.892

3.  Determination of end-tidal sevoflurane concentration for tracheal intubation and minimum alveolar anesthetic concentration in adults.

Authors:  T Kimura; S Watanabe; N Asakura; S Inomata; M Okada; M Taguchi
Journal:  Anesth Analg       Date:  1994-08       Impact factor: 5.108

4.  Age and solubility of volatile anesthetics in blood.

Authors:  J Lerman; G A Gregory; M M Willis; E I Eger
Journal:  Anesthesiology       Date:  1984-08       Impact factor: 7.892

5.  End-tidal sevoflurane concentration for tracheal intubation and minimum alveolar concentration in pediatric patients.

Authors:  S Inomata; S Watanabe; M Taguchi; M Okada
Journal:  Anesthesiology       Date:  1994-01       Impact factor: 7.892

6.  End-tidal sevoflurane concentrations for laryngeal mask airway insertion and for tracheal intubation in children.

Authors:  M Taguchi; S Watanabe; N Asakura; S Inomata
Journal:  Anesthesiology       Date:  1994-09       Impact factor: 7.892

7.  The pulmonary exchange of nitrous oxide and halothane in infants and children.

Authors:  E Salanitre; H Rackow
Journal:  Anesthesiology       Date:  1969-04       Impact factor: 7.892

8.  Partition coefficients for sevoflurane in human blood, saline, and olive oil.

Authors:  D P Strum; E I Eger
Journal:  Anesth Analg       Date:  1987-07       Impact factor: 5.108

9.  Clinical characteristics and biotransformation of sevoflurane in healthy human volunteers.

Authors:  D A Holaday; F R Smith
Journal:  Anesthesiology       Date:  1981-02       Impact factor: 7.892

10.  The minimum alveolar concentration (MAC) of sevoflurane in humans.

Authors:  T Katoh; K Ikeda
Journal:  Anesthesiology       Date:  1987-03       Impact factor: 7.892

View more
  6 in total

Review 1.  Sevoflurane in paediatric anaesthesia: a review.

Authors:  K L Goa; S Noble; C M Spencer
Journal:  Paediatr Drugs       Date:  1999 Apr-Jun       Impact factor: 3.022

2.  [Muscle relaxants are obligatory for pediatric intubation: pro].

Authors:  T Fuchs-Buder; J U Schreiber
Journal:  Anaesthesist       Date:  2011-05       Impact factor: 1.041

3.  Appropriate sevoflurane concentration to stabilize autonomic activity during intubation with rocuronium in infants: a randomized controlled trial.

Authors:  Hiroshi Hanamoto; Aiji Boku; Yoshinari Morimoto; Mitsutaka Sugimura; Chiho Kudo; Hitoshi Niwa
Journal:  BMC Anesthesiol       Date:  2015-04-29       Impact factor: 2.217

4.  Using fentanyl and propofol for tracheal intubation during sevoflurane induction without muscle relaxants in children: A randomized prospective study.

Authors:  Ashraf Arafat Abdelhalim; Hatem Hassan Maghraby; Ismail Ahmed ElZoughari; Tariq Abdullah AlZahrani; Mohamed Sayed Moustafa; Kamal Mohamed Alfassih; Abdulaziz Ejaz Ahmad
Journal:  Saudi J Anaesth       Date:  2017 Jul-Sep

5.  On-table extubation in neonates undergoing anoplasty: an experience of anesthetic management on the concept of fast-tracking anesthesia: A pilot study.

Authors:  Yu Cui; Yu Wang; Rong Cao; Kai Liu; Qing-Hua Huang; Bin Liu
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

6.  Minimum Alveolar Concentration of Sevoflurane with Cisatracurium for Endotracheal Intubation in Neonates.

Authors:  Bin Zhang; Junxia Wang; Mingzhuo Li; Feng Qi
Journal:  Med Sci Monit       Date:  2019-10-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.